Integrin αvβ8-Mediated TGF-β Activation by Effector Regulatory T Cells Is Essential for Suppression of T-Cell-Mediated Inflammation

Immunity

Volumn 42, Issue 5, 2015, Pages 903-915

  Worthington, John J ^a,b   Kelly, Aoife ^a,b   Smedley, Catherine ^a,b   Bauché, David ^c,d,e,f   Campbell, Simon ^g   Marie, Julien C ^c,d,e,f   Travis, Mark A ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^d UNIVERSITÉ LYON 1   (France)

^e LabEx DEVweCAN   (France)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAVBETA8 INTEGRIN; INTEGRIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; AUTACOID; INTEGRIN ALPHAVBETA8;

ANIMAL CELL; ARTICLE; CELL EXPANSION; CONTROLLED STUDY; HOMEOSTASIS; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; MOUSE; NONHUMAN; PATHOGENICITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; ANIMAL; BIOLOGICAL MODEL; CELL PROLIFERATION; COLITIS; CYTOLOGY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM;

ANIMALS; CELL PROLIFERATION; COLITIS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTEGRINS; MICE; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 84929710693     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2015.04.012     Document Type: Article

References (43)

1. Abe M., Harpel J.G., Metz C.N., Nunes I., Loskutoff D.J., Rifkin D.B. An assay for transforming growth factor-β using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem. 1994, 216:276-284.
2. Afzali B., Mitchell P.J., Edozie F.C., Povoleri G.A., Dowson S.E., Demandt L., Walter G., Canavan J.B., Scotta C., Menon B., et al. CD161 expression characterizes a subpopulation of human regulatory Tcells that produces IL-17 in a STAT3-dependent manner. Eur. J. Immunol. 2013, 43:2043-2054.
3. Andersson J., Tran D.Q., Pesu M., Davidson T.S., Ramsey H., O'Shea J.J., Shevach E.M. CD4+ FoxP3+ regulatory Tcells confer infectious tolerance in a TGF-β-dependent manner. J.Exp. Med. 2008, 205:1975-1981.
4. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., McGrady G., Wahl S.M. Conversion of peripheral CD4+CD25- naive Tcells to CD4+CD25+ regulatory Tcells by TGF-β induction of transcription factor Foxp3. J.Exp. Med. 2003, 198:1875-1886.
5. Dieckmann D., Plottner H., Berchtold S., Berger T., Schuler G. Exvivo isolation and characterization of CD4(+)CD25(+) Tcells with regulatory properties from human blood. J.Exp. Med. 2001, 193:1303-1310.
6. Edwards J.P., Fujii H., Zhou A.X., Creemers J., Unutmaz D., Shevach E.M. Regulation of the expression of GARP/latent TGF-β1 complexes on mouse Tcells and their role in regulatory Tcell and Th17 differentiation. J.Immunol. 2013, 190:5506-5515.
7. Edwards J.P., Thornton A.M., Shevach E.M. Release of active TGF-β1 from the latent TGF-β1/GARP complex on T regulatory cells is mediated by integrin β8. J.Immunol. 2014, 193:2843-2849.
8. Fahlén L., Read S., Gorelik L., Hurst S.D., Coffman R.L., Flavell R.A., Powrie F. T cells that cannot respond to TGF-β escape control by CD4(+)CD25(+) regulatory Tcells. J.Exp. Med. 2005, 201:737-746.
9. Feuerer M., Hill J.A., Kretschmer K., von Boehmer H., Mathis D., Benoist C. Genomic definition of multiple exvivo regulatory Tcell subphenotypes. Proc. Natl. Acad. Sci. USA 2010, 107:5919-5924.
10. Griseri T., McKenzie B.S., Schiering C., Powrie F. Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation. Immunity 2012, 37:1116-1129.
11. Gutcher I., Donkor M.K., Ma Q., Rudensky A.Y., Flavell R.A., Li M.O. Autocrine transforming growth factor-β1 promotes invivo Th17 cell differentiation. Immunity 2011, 34:396-408.
12. Jonuleit H., Schmitt E., Stassen M., Tuettenberg A., Knop J., Enk A.H. Identification and functional characterization of human CD4(+)CD25(+) Tcells with regulatory properties isolated from peripheral blood. J.Exp. Med. 2001, 193:1285-1294.
13. Komatsu N., Okamoto K., Sawa S., Nakashima T., Oh-hora M., Kodama T., Tanaka S., Bluestone J.A., Takayanagi H. Pathogenic conversion of Foxp3+ Tcells into TH17 cells in autoimmune arthritis. Nat. Med. 2014, 20:62-68.
14. Konkel J.E., Jin W., Abbatiello B., Grainger J.R., Chen W. Thymocyte apoptosis drives the intrathymic generation of regulatory Tcells. Proc. Natl. Acad. Sci. USA 2014, 111:E465-E473.
15. Kullberg M.C., Hay V., Cheever A.W., Mamura M., Sher A., Letterio J.J., Shevach E.M., Piccirillo C.A. TGF-β1 production by CD4+ CD25+ regulatory Tcells is not essential for suppression of intestinal inflammation. Eur. J. Immunol. 2005, 35:2886-2895.
16. Lahl K., Loddenkemper C., Drouin C., Freyer J., Arnason J., Eberl G., Hamann A., Wagner H., Huehn J., Sparwasser T. Selective depletion of Foxp3+ regulatory Tcells induces a scurfy-like disease. J.Exp. Med. 2007, 204:57-63.
17. Li M.O., Wan Y.Y., Flavell R.A. T cell-produced transforming growth factor-β1 controls Tcell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 2007, 26:579-591.
18. Liu H., Hu B., Xu D., Liew F.Y. CD4+CD25+ regulatory Tcells cure murine colitis: the role of IL-10, TGF-β, and CTLA4. J.Immunol. 2003, 171:5012-5017.
19. Liu Y., Zhang P., Li J., Kulkarni A.B., Perruche S., Chen W. A critical function for TGF-β signaling in the development of natural CD4+CD25+Foxp3+ regulatory Tcells. Nat. Immunol. 2008, 9:632-640.
20. Maloy K.J., Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011, 474:298-306.
21. Maloy K.J., Salaun L., Cahill R., Dougan G., Saunders N.J., Powrie F. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J.Exp. Med. 2003, 197:111-119.
22. Maloy K.J., Antonelli L.R.V., Lefevre M., Powrie F. Cure of innate intestinal immune pathology by CD4+CD25+ regulatory Tcells. Immunol. Lett. 2005, 97:189-192.
23. Marie J.C., Letterio J.J., Gavin M., Rudensky A.Y. TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory Tcells. J.Exp. Med. 2005, 201:1061-1067.
24. Miyara M., Yoshioka Y., Kitoh A., Shima T., Wing K., Niwa A., Parizot C., Taflin C., Heike T., Valeyre D., et al. Functional delineation and differentiation dynamics of human CD4+ Tcells expressing the FoxP3 transcription factor. Immunity 2009, 30:899-911.
25. Mu D., Cambier S., Fjellbirkeland L., Baron J.L., Munger J.S., Kawakatsu H., Sheppard D., Broaddus V.C., Nishimura S.L. The integrin α(v)β8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-β1. J.Cell Biol. 2002, 157:493-507.
26. Nakamura K., Kitani A., Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory Tcells is mediated by cell surface-bound transforming growth factor β. J.Exp. Med. 2001, 194:629-644.
27. Nakamura K., Kitani A., Fuss I., Pedersen A., Harada N., Nawata H., Strober W. TGF-β 1 plays an important role in the mechanism of CD4+CD25+ regulatory Tcell activity in both humans and mice. J.Immunol. 2004, 172:834-842.
28. Oida T., Xu L., Weiner H.L., Kitani A., Strober W. TGF-β-mediated suppression by CD4+CD25+ Tcells is facilitated by CTLA-4 signaling. J.Immunol. 2006, 177:2331-2339.
29. Pesu M., Watford W.T., Wei L., Xu L., Fuss I., Strober W., Andersson J., Shevach E.M., Quezado M., Bouladoux N., et al. T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance. Nature 2008, 455:246-250.
30. hi CD4+ T-cells. Immunity 1994, 1:553-562.
31. Rubtsov Y.P., Rasmussen J.P., Chi E.Y., Fontenot J., Castelli L., Ye X., Treuting P., Siewe L., Roers A., Henderson W.R., et al. Regulatory Tcell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008, 28:546-558.
32. Rudensky A.Y. Regulatory Tcells and Foxp3. Immunol. Rev. 2011, 241:260-268.
33. + Tcell homeostasis but dispensable for regulatory Tcell function. PLoS Biol. 2013, 11:e1001674.
34. Takahashi T., Kuniyasu Y., Toda M., Sakaguchi N., Itoh M., Iwata M., Shimizu J., Sakaguchi S. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive Tcells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 1998, 10:1969-1980.
35. Tang Q., Bluestone J.A. Regulatory T-cell therapy in transplantation: moving to the clinic. Cold Spring Harb Perspect Med 2013, 3.
36. Thornton A.M., Shevach E.M. CD4+CD25+ immunoregulatory Tcells suppress polyclonal Tcell activation invitro by inhibiting interleukin 2 production. J.Exp. Med. 1998, 188:287-296.
37. Travis M.A., Reizis B., Melton A.C., Masteller E., Tang Q., Proctor J.M., Wang Y., Bernstein X., Huang X., Reichardt L.F., et al. Loss of integrin α(v)β8 on dendritic cells causes autoimmunity and colitis in mice. Nature 2007, 449:361-365.
38. Workman C.J., Collison L.W., Bettini M., Pillai M.R., Rehg J.E., Vignali D.A. Invivo Treg suppression assays. Methods Mol. Biol. 2011, 707:119-156.
39. Worthington J.J., Klementowicz J.E., Travis M.A. TGFβ: a sleeping giant awoken by integrins. Trends Biochem. Sci. 2011, 36:47-54.
40. Worthington J.J., Czajkowska B.I., Melton A.C., Travis M.A. Intestinal dendritic cells specialize to activate transforming growth factor-β and induce Foxp3+ regulatory Tcells via integrin αvβ8. Gastroenterology 2011, 141:1802-1812.
41. Worthington J.J., Klementowicz J.E., Rahman S., Czajkowska B.I., Smedley C., Waldmann H., Sparwasser T., Grencis R.K., Travis M.A. Loss of the TGFβ-activating integrin αvβ8 on dendritic cells protects mice from chronic intestinal parasitic infection via control of type 2 immunity. PLoS Pathog. 2013, 9:e1003675.
42. Zhang X., Reddy J., Ochi H., Frenkel D., Kuchroo V.K., Weiner H.L. Recovery from experimental allergic encephalomyelitis is TGF-β dependent and associated with increases in CD4+LAP+ and CD4+CD25+ Tcells. Int. Immunol. 2006, 18:495-503.
43. Zhou X., Bailey-Bucktrout S.L., Jeker L.T., Penaranda C., Martínez-Llordella M., Ashby M., Nakayama M., Rosenthal W., Bluestone J.A. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory Tcells invivo. Nat. Immunol. 2009, 10:1000-1007.